Nielsen H, Kowalski A, Johansson L. "一种的合成方法" [P]. European Patent, EP 3985000 A1, 2015-10-21.
Johnson M A, O'Brien P Q, Thompson G K. "Method for the Synthesis of 5α-ANDROSTAN-3α, 16β, 17β-TRIOL" [P]. US Patent, US 9969411 B2, 2025-04-15.
发明人罗永刚,王建平,李文辉. "A Process for Preparing High-Purity 5α-ANDROSTAN-3α, 16β, 17β-TRIOL" [P]. 中国发明专利, 专利号 CN 117087521 A, 授权公告日 2017-01-15.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 2198, 4584-4588.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2015, 364, 7980-7995.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 5α-ANDROSTAN-3α, 16β, 17β-TRIOL Using HRMS and NMR". Anal. Methods, 2010, 2371, 2121-2150.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2012, 1636, (11), 1700-1727.